Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study
Shusaku Ishikawa1, Yoshimi Nakamura1, Yuko Nakamura1, Hiroshi Sakai1, Shoichi Sawaguchi1, Kazuo Terashima2, Makoto Kanno2, Hidetoshi Yamashita21Department of Ophthalmology, University of the Ryukyus Faculty of Medicine, Okinawa, Japan; 2Department of Ophthalmology and Visual Science, Yamagata Univer...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/161be59dc63f42bc94d7cc825734152e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:161be59dc63f42bc94d7cc825734152e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:161be59dc63f42bc94d7cc825734152e2021-12-02T01:15:10ZEfficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study1177-54671177-5483https://doaj.org/article/161be59dc63f42bc94d7cc825734152e2008-09-01T00:00:00Zhttp://www.dovepress.com/efficacy-and-safety-of-combination-therapy-with-latanoprost-after-a-ch-a2168https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Shusaku Ishikawa1, Yoshimi Nakamura1, Yuko Nakamura1, Hiroshi Sakai1, Shoichi Sawaguchi1, Kazuo Terashima2, Makoto Kanno2, Hidetoshi Yamashita21Department of Ophthalmology, University of the Ryukyus Faculty of Medicine, Okinawa, Japan; 2Department of Ophthalmology and Visual Science, Yamagata University Faculty of Medicine, Yamagata, JapanPurpose: To compare the efficacy of brinzolamide in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH) after a change from timolol in combination therapy with latanoprost.Methods: A 12-week, prospective, open-label, comparative study was performed in 20 patients [11 males and 9 females, mean age of 64.5 ± 11.0 (SD)y] with POAG or OH treated with both latanoprost once daily and timolol 0.5% twice daily. During the study brinzolamide was substituted for timolol. Intraocular pressure (IOP) was measured at baseline, 4, 8, and 12 weeks. Blood pressure (BP), pulse rate (PR), and adverse events were also recorded.Results: IOPs at baseline, 4, 8, and 12 weeks were 18.6 ± 2.1 mmHg, 17.8 ± 2.6 mmHg, 17.4 ± 2.5 mmHg, and 17.3 ± 3.5 mmHg, respectively. IOP reduction at 4 and 8 weeks was statistically significant (p < 0.05). The PR was significantly increased at 12 weeks (p < 0.01), but BP was not significantly affected. Four ocular adverse events were noted, but all were mild and transient.Conclusions: Substituting brinzolamide 1% for timolol 0.5% in combination therapy with latanoprost 0.005% demonstrated significant IOP reduction with improvement in PR with POAG or OH. Combination therapy using latanoprost and brinzolamide may be recommended for better IOP control with fewer systemic adverse events.Keywords: open-angle glaucoma, brinzolamide/latanprost combination therapy, timolol/latanoprost combination therapy, intraocular pressure Shusaku IshikawaYoshimi NakamuraYuko NakamuraHiroshi SakaiShoichi Sawaguchiet alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2008, Iss Issue 4, Pp 703-708 (2008) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Ophthalmology RE1-994 |
| spellingShingle |
Ophthalmology RE1-994 Shusaku Ishikawa Yoshimi Nakamura Yuko Nakamura Hiroshi Sakai Shoichi Sawaguchi et al Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
| description |
Shusaku Ishikawa1, Yoshimi Nakamura1, Yuko Nakamura1, Hiroshi Sakai1, Shoichi Sawaguchi1, Kazuo Terashima2, Makoto Kanno2, Hidetoshi Yamashita21Department of Ophthalmology, University of the Ryukyus Faculty of Medicine, Okinawa, Japan; 2Department of Ophthalmology and Visual Science, Yamagata University Faculty of Medicine, Yamagata, JapanPurpose: To compare the efficacy of brinzolamide in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH) after a change from timolol in combination therapy with latanoprost.Methods: A 12-week, prospective, open-label, comparative study was performed in 20 patients [11 males and 9 females, mean age of 64.5 ± 11.0 (SD)y] with POAG or OH treated with both latanoprost once daily and timolol 0.5% twice daily. During the study brinzolamide was substituted for timolol. Intraocular pressure (IOP) was measured at baseline, 4, 8, and 12 weeks. Blood pressure (BP), pulse rate (PR), and adverse events were also recorded.Results: IOPs at baseline, 4, 8, and 12 weeks were 18.6 ± 2.1 mmHg, 17.8 ± 2.6 mmHg, 17.4 ± 2.5 mmHg, and 17.3 ± 3.5 mmHg, respectively. IOP reduction at 4 and 8 weeks was statistically significant (p < 0.05). The PR was significantly increased at 12 weeks (p < 0.01), but BP was not significantly affected. Four ocular adverse events were noted, but all were mild and transient.Conclusions: Substituting brinzolamide 1% for timolol 0.5% in combination therapy with latanoprost 0.005% demonstrated significant IOP reduction with improvement in PR with POAG or OH. Combination therapy using latanoprost and brinzolamide may be recommended for better IOP control with fewer systemic adverse events.Keywords: open-angle glaucoma, brinzolamide/latanprost combination therapy, timolol/latanoprost combination therapy, intraocular pressure |
| format |
article |
| author |
Shusaku Ishikawa Yoshimi Nakamura Yuko Nakamura Hiroshi Sakai Shoichi Sawaguchi et al |
| author_facet |
Shusaku Ishikawa Yoshimi Nakamura Yuko Nakamura Hiroshi Sakai Shoichi Sawaguchi et al |
| author_sort |
Shusaku Ishikawa |
| title |
Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
| title_short |
Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
| title_full |
Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
| title_fullStr |
Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
| title_full_unstemmed |
Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
| title_sort |
efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study |
| publisher |
Dove Medical Press |
| publishDate |
2008 |
| url |
https://doaj.org/article/161be59dc63f42bc94d7cc825734152e |
| work_keys_str_mv |
AT shusakuishikawa efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT yoshiminakamura efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT yukonakamura efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT hiroshisakai efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT shoichisawaguchi efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy AT etal efficacyandsafetyofcombinationtherapywithlatanoprostafterachangeintherapeuticregimenfromtimololtobrinzolamideinjapaneseadultpatientswithprimaryopenangleglaucomaandocularhypertensionopennonrandomized12weekstudy |
| _version_ |
1718403181750255616 |